0.50 / AMA PRA Category 1 Credit(s)TM 0.50 / CE for Pharmacists (0.05 CEUs)
This activity is provided by Haymarket Medical Education for physician credit.
This activity is provided by Global Education Group for pharmacy contact hours.
Supported by an educational grant from Boehringer Ingelheim
Effective communication is essential to fostering collaborative care among patients with chronic obstructive pulmonary disease (COPD). Patients need to know which medicines to take on a daily basis and when and why to take them; how to control COPD long term; how to recognize exacerbation symptoms; when and how to use oxygen therapy and physical therapy; the importance of medication adherence; when to call a doctor or go to the emergency room; and how to manage comorbidities. A written action plan is key, including one for patients discharged from the hospital after being admitted for an acute exacerbation. Further, any COPD patient given inhaled therapy should receive a demonstration of inhaler use, with refresher demonstrations and counseling at every subsequent visit. Referral to pulmonary rehabilitation should be followed up with regular encouragement for participation. In every interaction, clinicians must reinforce the need for self-management—medication adherence, proper medication use, regular attendance at rehabilitation and exercise training sessions, avoidance of smoking, and prompt reporting of any changes in symptom patterns or function.
Family medicine and internal medicine (IM) clinicians (MDs/DOs, physician assistants [PAs], nurse practitioners [NPs]), and pharmacists who are involved in the care of patients with COPD
After completing the activity, the participant should be better able to:
Implement strategies for early recognition and management of stable chronic obstructive pulmonary disease (COPD) and for prevention as well as management of acute exacerbations
Review and synthesize expert guidelines for COPD assessment and management, so as to optimally choose from the many treatment agents available
Develop strategies for coordinating COPD care across multiple disciplines and care settings to help improve access to supportive services, enhance the level of care for COPD and comorbidities, and reduce hospital readmissions
Establish specific protocols for educating COPD patients about their disease, associated risk factors, treatment options, adherence to treatment regimens, and overall goals of therapy
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Keith T. Kanel, MD, MHCM, FACP Clinical Associate Professor of Medicine University of Pittsburgh School of Medicine Pittsburgh, PA
Dr. Kanel has no relevant financial relationships to disclose.
Lori Ann Wilken, PharmD, AE-C, BCACP, TT-S Clinical Assistant Professor University of Illinois at Chicago College of Pharmacy Clinical Pulmonary Pharmacist Director, Tobacco Treatment Center University of Illinois Hospital and Health Sciences System Chicago, IL
Dr. Wilken has no relevant financial relationships to disclose.
Accredited Provider Disclosures
Angie Ladas, Lori Marrese, and Nick Zittell of Haymarket Medical Education have no relevant financial relationships to disclose.
Lindsay Borvansky, Andrea Funk, Karen Kaufman, and Liddy Knight of Global Education Group have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Pharmacists
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 0.50 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education. Universal Program Number: 0530-9999-18-093-H01-P.
This is a knowledge-based activity.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, Global Education Group, or Boehringer Ingelheim. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
Global protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the customer’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.